Personal information

Verified email addresses

SARS-CoV-2, Recombinant Proteins, RNA, repRNA, Melanome
Brazil, United States

Biography

Graduated in Biomedicine from Centro Universitário Jorge Amado (UNIJORGE). Currently, Master's student in Biotechnology in Health and Investigative Medicine - Pgbsmi from Fiocruz - Instituto Gonçalo Moniz. Worked on the Senai Cimatec Vaccine Project by CNPQ as DT-I C: Phase I and II clinical studies to evaluate the efficacy and safety of a new vaccine candidate for COVID-19 formulated in a nanoparticle carrying Replicon RNA (repRNA) self-replicating (2023). He worked in Scientific Initiation at SENAI Cimatec in the area of ​​research in the production of the RepRNA/LION formulation with variants of the SARS-CoV-2 Spike protein (2021-2022). He worked at the Central Laboratory - Hospital Jorge Novis as part of the mandatory supervised internship I and II in the area of ​​Clinical Analysis (2022). She worked as a Monitor for the General and Metabolic Biochemistry discipline at Centro Universitário Jorge Amado (2021). Served as Communication Director of the Academic League of Biomedicine with Multidisciplinary Extension (2020). Experience in Molecular Biology, Microbiology, Cell Cultivation and Biotechnology, focusing on the production of DNA, RNA, replicon RNA, recombinant proteins, PCR, immunological assays ( Western Blotting, ELISA), gel electrophoresis, affinity chromatography. Experience with scientific writing, production of tables and graphs.

Activities

Employment (2)

SENAI CIMATEC: Salvador, Bahia, BR

2023-01 to 2023-02 | Industrial Technological Development Graduate Scholarship (SENAI - Regional Department of Bahia, SENAI/DR/BA, Brazil)
Employment
Source: Self-asserted source
Eduarda Lima

SENAI CIMATEC: Salvador, Bahia, BR

2021-06 to 2022-12 | scientific initiation scholarship (SENAI - Regional Department of Bahia, SENAI/DR/BA, Brazil)
Employment
Source: Self-asserted source
Eduarda Lima

Education and qualifications (1)

Fundação Oswaldo Cruz: Salvador, Bahia, BR

2023-05 to 2025-05 | Master's student (Gonçalo Moniz Institute- Oswaldo Cruz Fundation)
Education
Source: Self-asserted source
Eduarda Lima

Funding (2)

Preclinical development of the LION/repRNA-IL-15 formulation for melanoma immunotherapy

2023-06 to 2025-05 | Contract
Coordenação de Aperfeicoamento de Pessoal de Nível Superior (Brasília, Bahia, BR)
GRANT_NUMBER:

88887.878250/2023-00

Source: Self-asserted source
Eduarda Lima

Phase I and II Clinical Studies to evaluate the efficacy and safety of a new vaccine candidate for COVID-19 formulated in a nanoparticle carrying self-replicating Replicon RNA (repRNA)

2023-01 to 2023-01 | Contract
Conselho Nacional de Desenvolvimento Científico e Tecnológico (Salvador, Bahia, BR)
Source: Self-asserted source
Eduarda Lima

Works (2)

RNA Combined with Nanoformulation to Advance Therapeutic Technologies

Pharmaceuticals
2023-11 | Journal article | Author
Contributors: Eduarda Lima; Déborah dos Santos; Atena Liriel Souza; Maria Eduarda Macedo; Mariana Evangelista Bandeira; Sergio Santos Silva Junior; Bianca Sampaio Dotto Fiuza; Vinicius Pinto Costa Rocha; Larissa Fonseca; Danielle Devequi Gomes Nunes et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Heterologous Expression, Purification, and Immune-Based Assay Application of Soluble SARS-CoV-2 Nucleocapsid Protein.

The Journal of Bioengineering, Technologies and Health
2022 | Magazine article | Methodology, Investigation
Contributors: Eduarda Lima; Vinicius Pinto Costa Rocha; Mariana Evangelista Bandeira; Cássio Meira; Breno Cardim; Emanuelle de Souza Santos; Milena Soares
Source: Self-asserted source
Eduarda Lima